Skip to content
TrustList
Collider Ventures logo
Investor

Collider Ventures

An Israeli crypto venture fund making early-stage investments across DeFi and web3 infrastructure

Collider Ventures cover

About Collider Ventures

Collider is a crypto venture fund based in Israel that makes early-stage investments, from pre-seed to Series A, across decentralised finance, infrastructure, privacy technology and Bitcoin-related layers. Its portfolio includes Safe, The Graph, EtherFi, Fhenix and CoW Protocol. The firm's research team was awarded a bug bounty by GMX after discovering a major vulnerability in its systems, an episode it has written up on its own site as part of its research work. Collider also publishes commentary on crypto market and policy developments, including on stablecoins and government debt, and describes its own approach as transparent and direct, saying it backs founders it considers to show conviction and a distinctly Israeli willingness to challenge convention, treating its invested capital as ultimately replaceable compared with that spirit.

Profile written by TrustList from the business's own published information, Sep 2026.

Ask TrustList to introduce you to Collider Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Collider Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Collider Ventures.

Collider Ventures alternatives

Similar listings buyers compare against this one.

Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Desktop office software with a word processor, spreadsheet, presentations and PDF tools for individuals

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Innovation platform running accelerator programmes and startup investments that link corporations with young technology companies

San Francisco early-stage technology venture firm led by two founding partners with a stated humane-technology outlook